LOGO 2120 (Valproic acid 250 mg)
Pill imprint LOGO 2120 has been identified as Valproic acid 250 mg.
Valproic acid is used in the treatment of bipolar disorder; migraine prevention; seizure prevention; cluster-tic syndrome; schizoaffective disorder (and more), and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Valproic acid 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for LOGO 2120
- 250 mg
- Prescription only
- Drug Class:
- Fatty acid derivative anticonvulsants
- Pregnancy Category:
- D - Positive evidence of risk - When treating epilepsy
X - Not for use in pregnancy - When treating migraine
- CSA Schedule:
- N - Not a controlled drug
- United Research Laboratories/Mutual Pharmaceutical Company
More about valproic acid
- Valproate Syrup
- Valproic acid
- Valproic acid delayed-release capsules
- Valproic acid syrup
- More (2) »
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.